Seventeen-year experience with the St. Jude medical biocor porcine bioprosthesis

Journal of Heart Valve Disease

Volumn 14, Issue 4, 2005, Pages 486-492

  Mykén, Pia S ^a  

^a SAHLGRENSKA UNIVERSITY HOSPITAL   (Sweden)

Author keywords

[No Author keywords available]

Indexed keywords

ANTICOAGULANT AGENT;

AGED; AORTA VALVE REPLACEMENT; ARTICLE; BIOPROSTHESIS; BLEEDING; CONTROLLED STUDY; FEMALE; FOLLOW UP; HUMAN; MITRAL VALVE REPLACEMENT; PRIORITY JOURNAL; QUESTIONNAIRE; REOPERATION; SURGICAL MORTALITY; THROMBOEMBOLISM; AGE; AORTA VALVE; ENDOCARDITIS; HEART VALVE PROSTHESIS; HEART VALVE REPLACEMENT; INFECTION; LONGITUDINAL STUDY; MALE; MIDDLE AGED; MITRAL VALVE; MORTALITY; POSTOPERATIVE COMPLICATION; PROSTHESIS; PROSTHESIS FAILURE; STATISTICS; VALVULAR HEART DISEASE;

AGE FACTORS; AGED; ANTICOAGULANTS; AORTIC VALVE; BIOPROSTHESIS; ENDOCARDITIS; FEMALE; HEART VALVE DISEASES; HEART VALVE PROSTHESIS; HEART VALVE PROSTHESIS IMPLANTATION; HUMANS; LONGITUDINAL STUDIES; MALE; MIDDLE AGED; MITRAL VALVE; POSTOPERATIVE COMPLICATIONS; PROSTHESIS DESIGN; PROSTHESIS FAILURE; PROSTHESIS-RELATED INFECTIONS; REOPERATION; THROMBOEMBOLISM;

EID: 33644656308     PISSN: 09668519     EISSN: None     Source Type: Journal    
DOI: None     Document Type: Article

References (27)

1. Northrup WF, III, Dubois KA, Kshettry VR, Teskey JM, Nicoloff DM. Trends in aortic valve surgery in a large multi-surgeon, multi-hospital practice, 1979-1999. J Heart Valve Dis 2002;11:768-778; discussion 778-779
2. Edwards MB, Taylor KM. A profile of valve replacement surgery in the UK (1986-1997): A study from the UK Heart Valve Registry. J Heart Valve Dis 1999;8:697-701
3. Oxenham H, Bloomfield P, Wheatley DJ, et al. Twenty year comparison of a Björk-Shiley mechanical heart valve with porcine bioprostheses. Heart 2003;89:715-721
4. Bonow RO, Carabello B, de Leon AC, et al. ACC/AHA Guidelines for the Management of Patients With Valvular Heart Disease. Executive Summary. A report of the American College of Cardiology/American Heart Association Task Force on Practice Guidelines (Committee on Management of Patients With Valvular Heart Disease). J Heart Valve Dis 1998;7:672-707
5. Broom ND, Thomson PJ. Influence of fixation conditions on performance of glutaraldehyde-treated porcine aortic valve: Towards a more scientific basis. Thorax 1979;34:166-176
6. Mayne ASD, Christie OW, Smaill BH, Hunter PJ, Barrett-Boyes BO. An assessment of the mechanical properties of leaflets from four second generation porcine bioprostheses using biaxial testing techniques. J Thorac Cardiovasc Surg 1989;98:170-180
7. Hilbert SL, Barrick MK. Porcine aortic valve bioprostheses: A morphologic comparison of the effects of fixation pressure. J Biomed Mater Res 1990;24:773-787
8. Vesely I. Analysis of the Medtronic Intact bioprosthetic valve: Effects of 'zero-pressure' fixation. J Thorac Cardiovasc Surg 1991;101:90-99
9. Mykén P, Bech-Hanssen O, Phipps B, Caidahl K. Fifteen years follow up with the St. Jude Medical Biocor porcine bioprosthesis. J Heart Valve Dis 2000;9:415-422
10. Edmunds LH, Jr., Clark RE, Cohn LH, Grunkemeier GL, Miller DC, Weisel RD. Guidelines for reporting morbidity and mortality after cardiac valvular operations. Ad Hoc Liaison Committee for Standardizing Definitions of Prosthetic Heart Valve Morbidity of The American Association for Thoracic Surgery and The Society of Thoracic Surgeons. J Thorac Cardiovasc Surg 1996;112:708-711
11. Banbury MK, Cosgrove DM, III, White JA, Blackstone EH, Frater RW, Okies JE. Age and valve size effect on the long-term durability of the Carpentier-Edwards aortic pericardial bioprosthesis. Ann Thorac Surg 2001;72:753-757
12. David TE, Ivanov J, Armstrong S, et al. Late results of heart valve replacement with the Hancock II bioprosthesis. J Thorac Cardiovasc Surg 2001;121:268-277
13. Marchand MA, Aupart MR, Norton R, et al. Fifteen-year experience with the mitral Carpentier-Edwards PERIMOUNT pericardial bioprosthesis. Ann Thorac Surg 2001;71(5 Suppl.):S236-S239
14. Jamieson WR, Janusz MT, Burr LH, et al. Carpentier-Edwards supraannular porcine bioprosthesis: Second-generation prosthesis in aortic valve replacement. Ann Thorac Surg 2001;71(5 Suppl.):S224-S227
15. Kirali K, Güler M, Tuncer A, et al. Fifteen-year clinical experience with the Biocor porcine bioprostheses in the mitral position. Ann Thorac Surg 2001;71:811-815
16. Walther T, Falk V, Langebartels G, et al. Regression of left ventricular hypertrophy after stentless versus conventional aortic valve replacement. Semin Thorac Cardiovasc Surg 1999;11(4 Suppl.1):18-21
17. Bevilacqua S, Gianetti J, Ripoli A, et al. Aortic valve disease with severe ventricular dysfunction: Stentless valve for better recovery. Ann Thorac Surg 2002;74:2016-2021
18. Sensky PR, Loubani M, Keal RP, Samani NJ, Sosnowski AW, Galinanes M. Does the type of prosthesis influence early left ventricular mass regression after aortic valve replacement? Assessment with magnetic resonance imaging. Am Heart J 2003;146:E13
19. Bach DS, Goldman B, Verrier E, et al. Eight-year hemodynamic follow-up after aortic valve replacement with the Toronto SPV stentless aortic valve. Semin Thorac Cardiovasc Surg 2001;13(4 Suppl.1):173-179
20. Dellgren G, Eriksson MJ, Brodin LA, Radegran K. Eleven years' experience with the Biocor stentless aortic bioprosthesis: Clinical and hemodynamic follow-up with long-term relative survival rate. Eur J Cardiothorac Surg 2002;22:912-921
21. Bach DS, Goldman B, Verrier E, et al. Durability and prevalence of aortic regurgitation nine years after aortic valve replacement with the Toronto SPV stentless bioprosthesis. J Heart Valve Dis 2004;13:64-72
22. Butchart EG, Ionescu A, Payne N, Giddings J, Grunkemeier GL, Fraser AG. A new scoring system to determine thromboembolic risk after heart valve replacement. Circulation 2003;108(Suppl.1):II68-II74
23. Rahimtoola SH. Choice of prosthetic heart valve for adult patients. J Am Coll Cardiol 2003;41:893-904
24. Kolominsky-Rabas PL, Sarti C, Heuschmann PU, et al. A prospective community-based study of stroke in Germany - the Erlangen Stroke Project (ESPro): Incidence and case fatality at 1, 3, and 12 months. Stroke 1998;29:2501-2506
25. Brown RD, Jr., Petty GW, O'Fallon WM, Wiebers DO, Whisnant JP. Incidence of transient ischemic attack in Rochester, Minnesota, 1985-1989. Stroke 1998;29:2109-2113
26. Gherli T, Colli A, Fragnito C, et al. Comparing warfarin with aspirin after biological aortic valve replacement: A prospective study. Circulation 2004;110:496-500
27. Jamieson WR, Burr LH, Miyagishima RT, Germann E, Anderson WN. Actuarial versus actual freedom from structural valve deterioration with the Carpentier-Edwards porcine bioprostheses. Can J Cardiol 1999;15:973-978